PMDA drug package insert
ホームパスフェルビナファインα
PMDA OTC drug · （株）大石膏盛堂 · package insert May 27, 2020
Key facts
| Brand names | ホームパスフェルビナファインα |
|---|---|
| Companies | 製造販売元／（株）大石膏盛堂 |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 貼付剤 |
| OTC effect category | 鎮痛・鎮痒・収れん・消炎薬（パップ剤を含む） |
| Package insert date | May 27, 2020 |
| PMDA document key | 180012_K1610000002 |
| PMDA company code | 180012 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: